Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo

Stable vitiligo significantly impacts patients’ quality of life and presents a considerable challenge to healthcare providers. In recent years, cell therapy has emerged as a promising treatment for stable vitiligo, which is demonstrated encouraging results. Among current cell-based therapies, autolo...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianren Zheng, Jie Chen, Yixun Huang, Weikai Chen, Dandan Cheng, Qianqian Jia, Meiqin Zhu, Youguo Liao, Qiulin He, Shunli Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1583271/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849312066937028608
author Qianren Zheng
Jie Chen
Yixun Huang
Weikai Chen
Dandan Cheng
Qianqian Jia
Meiqin Zhu
Youguo Liao
Qiulin He
Qiulin He
Shunli Wu
Shunli Wu
author_facet Qianren Zheng
Jie Chen
Yixun Huang
Weikai Chen
Dandan Cheng
Qianqian Jia
Meiqin Zhu
Youguo Liao
Qiulin He
Qiulin He
Shunli Wu
Shunli Wu
author_sort Qianren Zheng
collection DOAJ
description Stable vitiligo significantly impacts patients’ quality of life and presents a considerable challenge to healthcare providers. In recent years, cell therapy has emerged as a promising treatment for stable vitiligo, which is demonstrated encouraging results. Among current cell-based therapies, autologous epidermal cell transplantation is regarded as a safe and cost-effective strategy. However, the therapeutic outcome critically depends on the retention and viability of the transplanted cells at the target site. Therefore, there is an urgent need to develop novel strategies to improve cell retention and maintain cell viability for improving therapeutic efficacy. In this work, a novel cell extraction method was first developed with deal with 2 h at 37°C to obtain epidermal cells while maintaining high cell viability. Subsequently, the crosslinked hyaluronic acid (HA) by BDDE was utilized as 3D scaffold for cell delivery to treat stable vitiligo. By combining the new extraction method with the HA-based hydrogel scaffold, we achieved prolonged cell retention without compromising cell viability. This approach provides a promising, time-saving strategy for treating stable vitiligo using autologous epidermal cells.
format Article
id doaj-art-ff193b20c9f14e2bb5a43c05d84505e1
institution Kabale University
issn 2296-858X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-ff193b20c9f14e2bb5a43c05d84505e12025-08-20T03:53:12ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-05-011210.3389/fmed.2025.15832711583271Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligoQianren Zheng0Jie Chen1Yixun Huang2Weikai Chen3Dandan Cheng4Qianqian Jia5Meiqin Zhu6Youguo Liao7Qiulin He8Qiulin He9Shunli Wu10Shunli Wu11Hangzhou Singclean Medical Products Co., Ltd, Hangzhou, ChinaDepartment of Student Affairs, Jiaxing Vocational Technical College, Jiaxing, Zhejiang, ChinaDepartment of Orthopedics, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Gynecological Oncology, Wenzhou Central Hospital, Wenzhou, Zhejiang, ChinaHangzhou Singclean Medical Products Co., Ltd, Hangzhou, ChinaHangzhou Singclean Medical Products Co., Ltd, Hangzhou, ChinaDepartment of Burns and Wound Care Center, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaHangzhou Singclean Medical Products Co., Ltd, Hangzhou, ChinaDepartment of Macromolecular Science, Fudan University, Shanghai, ChinaHangzhou Singclean Medical Products Co., Ltd, Hangzhou, ChinaCollege of Marine Life Sciences, Ocean University of China, Qingdao, Shandong, ChinaStable vitiligo significantly impacts patients’ quality of life and presents a considerable challenge to healthcare providers. In recent years, cell therapy has emerged as a promising treatment for stable vitiligo, which is demonstrated encouraging results. Among current cell-based therapies, autologous epidermal cell transplantation is regarded as a safe and cost-effective strategy. However, the therapeutic outcome critically depends on the retention and viability of the transplanted cells at the target site. Therefore, there is an urgent need to develop novel strategies to improve cell retention and maintain cell viability for improving therapeutic efficacy. In this work, a novel cell extraction method was first developed with deal with 2 h at 37°C to obtain epidermal cells while maintaining high cell viability. Subsequently, the crosslinked hyaluronic acid (HA) by BDDE was utilized as 3D scaffold for cell delivery to treat stable vitiligo. By combining the new extraction method with the HA-based hydrogel scaffold, we achieved prolonged cell retention without compromising cell viability. This approach provides a promising, time-saving strategy for treating stable vitiligo using autologous epidermal cells.https://www.frontiersin.org/articles/10.3389/fmed.2025.1583271/fullautologous epidermal melanocytescrosslinked hyaluronic acid hydrogelcell therapystable vitiligonude mice
spellingShingle Qianren Zheng
Jie Chen
Yixun Huang
Weikai Chen
Dandan Cheng
Qianqian Jia
Meiqin Zhu
Youguo Liao
Qiulin He
Qiulin He
Shunli Wu
Shunli Wu
Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo
Frontiers in Medicine
autologous epidermal melanocytes
crosslinked hyaluronic acid hydrogel
cell therapy
stable vitiligo
nude mice
title Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo
title_full Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo
title_fullStr Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo
title_full_unstemmed Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo
title_short Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo
title_sort injectable crosslinked ha hydrogel a promising carrier for cell transplantation to treat stable vitiligo
topic autologous epidermal melanocytes
crosslinked hyaluronic acid hydrogel
cell therapy
stable vitiligo
nude mice
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1583271/full
work_keys_str_mv AT qianrenzheng injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT jiechen injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT yixunhuang injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT weikaichen injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT dandancheng injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT qianqianjia injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT meiqinzhu injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT youguoliao injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT qiulinhe injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT qiulinhe injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT shunliwu injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo
AT shunliwu injectablecrosslinkedhahydrogelapromisingcarrierforcelltransplantationtotreatstablevitiligo